Literature DB >> 26244521

Studying Cellular Signal Transduction with OMIC Technologies.

Benjamin D Landry1, David C Clarke2, Michael J Lee3.   

Abstract

In the gulf between genotype and phenotype exists proteins and, in particular, protein signal transduction systems. These systems use a relatively limited parts list to respond to a much longer list of extracellular, environmental, and/or mechanical cues with rapidity and specificity. Most signaling networks function in a highly non-linear and often contextual manner. Furthermore, these processes occur dynamically across space and time. Because of these complexities, systems and "OMIC" approaches are essential for the study of signal transduction. One challenge in using OMIC-scale approaches to study signaling is that the "signal" can take different forms in different situations. Signals are encoded in diverse ways such as protein-protein interactions, enzyme activities, localizations, or post-translational modifications to proteins. Furthermore, in some cases, signals may be encoded only in the dynamics, duration, or rates of change of these features. Accordingly, systems-level analyses of signaling may need to integrate multiple experimental and/or computational approaches. As the field has progressed, the non-triviality of integrating experimental and computational analyses has become apparent. Successful use of OMIC methods to study signaling will require the "right" experiments and the "right" modeling approaches, and it is critical to consider both in the design phase of the project. In this review, we discuss common OMIC and modeling approaches for studying signaling, emphasizing the philosophical and practical considerations for effectively merging these two types of approaches to maximize the probability of obtaining reliable and novel insights into signaling biology.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  OMIC technologies; data-driven modeling; signal transduction; systems biology

Mesh:

Substances:

Year:  2015        PMID: 26244521      PMCID: PMC4818567          DOI: 10.1016/j.jmb.2015.07.021

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  140 in total

1.  Improving validation practices in "omics" research.

Authors:  John P A Ioannidis; Muin J Khoury
Journal:  Science       Date:  2011-12-02       Impact factor: 47.728

2.  An error model for protein quantification.

Authors:  C Kreutz; M M Bartolome Rodriguez; T Maiwald; M Seidl; H E Blum; L Mohr; J Timmer
Journal:  Bioinformatics       Date:  2007-09-03       Impact factor: 6.937

3.  The potential cost of high-throughput proteomics.

Authors:  Forest M White
Journal:  Sci Signal       Date:  2011-02-15       Impact factor: 8.192

Review 4.  Criteria for biological reproducibility: what does "n" mean?

Authors:  Kristen Naegle; Nancy R Gough; Michael B Yaffe
Journal:  Sci Signal       Date:  2015-04-07       Impact factor: 8.192

5.  Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells.

Authors:  Raoul Tibes; Yihua Qiu; Yiling Lu; Bryan Hennessy; Michael Andreeff; Gordon B Mills; Steven M Kornblau
Journal:  Mol Cancer Ther       Date:  2006-10       Impact factor: 6.261

6.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

7.  Sequential application of anticancer drugs enhances cell death by rewiring apoptotic signaling networks.

Authors:  Michael J Lee; Albert S Ye; Alexandra K Gardino; Anne Margriet Heijink; Peter K Sorger; Gavin MacBeath; Michael B Yaffe
Journal:  Cell       Date:  2012-05-11       Impact factor: 41.582

8.  Adaptive informatics for multifactorial and high-content biological data.

Authors:  Bjorn L Millard; Mario Niepel; Michael P Menden; Jeremy L Muhlich; Peter K Sorger
Journal:  Nat Methods       Date:  2011-04-24       Impact factor: 28.547

9.  A method for high-throughput gene expression signature analysis.

Authors:  David Peck; Emily D Crawford; Kenneth N Ross; Kimberly Stegmaier; Todd R Golub; Justin Lamb
Journal:  Genome Biol       Date:  2006       Impact factor: 13.583

10.  Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapy.

Authors:  Jinyan Du; Paula Bernasconi; Karl R Clauser; D R Mani; Stephen P Finn; Rameen Beroukhim; Melissa Burns; Bina Julian; Xiao P Peng; Haley Hieronymus; Rebecca L Maglathlin; Timothy A Lewis; Linda M Liau; Phioanh Nghiemphu; Ingo K Mellinghoff; David N Louis; Massimo Loda; Steven A Carr; Andrew L Kung; Todd R Golub
Journal:  Nat Biotechnol       Date:  2008-12-21       Impact factor: 54.908

View more
  3 in total

Review 1.  Exploiting Synthetic Lethality and Network Biology to Overcome EGFR Inhibitor Resistance in Lung Cancer.

Authors:  Simon Vyse; Annie Howitt; Paul H Huang
Journal:  J Mol Biol       Date:  2017-05-03       Impact factor: 5.469

2.  Integrated Strategies to Gain a Systems-Level View of Dynamic Signaling Networks.

Authors:  Robert H Newman; Jin Zhang
Journal:  Methods Enzymol       Date:  2017-03-07       Impact factor: 1.600

Review 3.  Analyzing signaling activity and function in hematopoietic cells.

Authors:  Tobias Kull; Timm Schroeder
Journal:  J Exp Med       Date:  2021-06-15       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.